Wells Fargo Rates Nuvalent (NUVL) hold, $124 Price Target
Wells Fargo lowered its rating on NUVL to hold on June 9, 2026, with a $124 price target, a 0.61% upside from the current price.
Reviewed by automated data checks against the source data. How we make and check alerts
Wells Fargo rated Nuvalent Inc ($NUVL) "hold" with a $124 price target on June 9, 2026.
Since the rating, $NUVL is up 0.1% after 1 week and up 0.1% to date (from the $123.25 close on Jun 9, 2026).
NUVL
Nuvalent Inc
Key Points
- Wells Fargo downgraded NUVL to a hold on June 9, 2026, setting a price target of $124.
- Wells Fargo's $124 price target implies 0.61% upside from Nuvalent Inc's ($NUVL) current $123.25 share price.
- NUVL shares are trading at $123.25 amid mixed institutional activity, including a 40% increase by JPMorgan Chase & Co.
- Insider activity includes planned sales by top executives, and multiple analysts have also downgraded the stock.
Get $NUVL trade alerts by text
We text you when insiders, Congress or big funds trade $NUVL. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Nuvalent Inc alert may contain errors. Disclosures
Wells Fargo recently downgraded NUVL to a hold rating on June 9, 2026, while setting a price target of $124. This move comes as the stock trades at $123.25.
Other Institutional Activity in NUVL
There has been varied activity among major institutional investors in NUVL. Deerfield Management Company maintained its position with 17,248,450 shares valued at about $1.77 billion. FMR LLC reduced its stake by 1,577,925 shares, ending with 9,274,959 shares worth approximately $950.2 million. Meanwhile, Paradigm Biocapital Advisors LP added 55,000 shares to hold 5,324,433 shares valued at around $545.5 million. BlackRock, Inc. slightly increased its holdings by 19,524 shares, now holding 4,824,785 shares worth about $494.3 million. JPMorgan Chase & Co notably increased its position by 883,098 shares, totaling 3,088,349 shares valued at about $298.7 million.
NUVL Stock Snapshot
Shares of NUVL are trading at $123.25. The stock has seen varied institutional interest, indicating a mixed outlook among investors.
$NUVL price target
Nuvalent Inc daily closes and this analyst's $124 target. Not advice.
Insider Buying and Selling at Nuvalent Inc
Recent insider activity includes transactions by key executives. On June 9, 2026, Darlene Noci, Chief Development Officer, sold 20,000 shares at an undisclosed price in a planned transaction, while also buying 20,000 shares at $9.59. On June 8, 2026, President and CEO James Richard Porter sold 30,000 shares at a planned price of $88.53, while also purchasing 30,000 shares at $18.93.
Analysts Set New Price Targets
Several analysts have recently updated their ratings and price targets for NUVL. On June 10, 2026, TD Cowen, Barclays, UBS, and Guggenheim all downgraded the stock to a hold, each setting a $124 price target. On June 9, 2026, Wells Fargo, HC Wainwright & Co., Wedbush, and LifeSci Capital also downgraded NUVL to a hold with the same target price of $124.
Bottom Line
The recent downgrade by Wells Fargo and similar moves by other analysts suggest a cautious outlook for NUVL. Institutional activities show mixed confidence, with some funds increasing their stakes while others reduce. Insider sales also highlight potential caution among executives. As with all 13F filings and analyst reports, these reflect past decisions and may not indicate future performance.
Related Filing Alerts
Source: Wells Fargo's rating change on $NUVL (Jun 9, 2026). Written by software, not financial advice. How we make alerts